[1. Thygesen K, Mair J, Mueller C, Huber K, Weber M, Plebani, et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J 2012;33(16):2001-6. DOI: 10.1093/ eurheartj/ehq50910.1093/eurheartj/ehq509]Search in Google Scholar
[2. Sudoh T, Maekawa K, Kojima M, Minamino N, Kangawa K, Matsuo H, et al. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun. 1989;159(3):1427-34. DOI: 10.1016/0006-291X(89)92269-910.1016/0006-291X(89)92269-9]Search in Google Scholar
[3. Mair J. Biochemistry of B-type natriuretic peptide? where are we now? Clin Chem Lab Med 2008;46(11):1507-14.]Search in Google Scholar
[4. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem. 2004;50(1):33-50. DOI: 10.1373/clinchem.2003.02476010.1373/clinchem.2003.02476014633912]Search in Google Scholar
[5. Baicu CF, Zile MR, Aurigemma GP, Gaasch WH. Left ventricular systolic performance, function and contractility in patients with diastolic heart failure. Circulation. 2005;111(18):2306-12. DOI: 10.1161/01. CIR.0000164273.57823.26]Search in Google Scholar
[6. Zdrenghea D, Ilea M, Pop D, Petrovai D, Bodisz G, Zdrenghea M. N-terminal Pro B-type Natriuretic Peptide During Exercise In Patients With Systolic And Diastolic Heart Failure. Acta Endocrinologica (Buc). 2009;5(1):19-25. DOI: 10.4183/aeb.2009.1910.4183/aeb.2009.19]Search in Google Scholar
[7. Ilea M, Zdrenghea D, Bodisz G, Malai A, Gheorghiu L, Predescu D, et al. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients. Rom J Intern Med. 2008;46(1):63-8.]Search in Google Scholar
[8. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al . The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33(14):1787-847. DOI: 10.1093/eurheartj/ehs10410.1093/eurheartj/ehs10422611136]Search in Google Scholar
[9. Zdrenghea D, Beudean M, Pop D, Zdrenghea V. Four hundred meters walking test in the evaluation of heart failure patients. Rom J Intern Med. 2010;48(1):33-8.]Search in Google Scholar
[10. Konstam MA. Natriuretic peptides and cardiovascular events:more than a stretch. JAMA. 2007;297(2):212-4. DOI: 10.1001/jama.297.2.21210.1001/jama.297.2.21217213406]Search in Google Scholar
[11. Guglin M, Hourani R, Pitta S. Factors Determin ing Extreme Brain Natriuretic Peptide Elevation. Congestive Heart Failure. 2007;13(3):136-41. DOI: 10.1111/j.1527-5299.2007.06478.x10.1111/j.1527-5299.2007.06478.x17541308]Search in Google Scholar
[12. Kallistratos MS, Pavlidis AN, Chamodraka ES, Varounis C, Dritsas A, Laoutaris ID, et al. Prognostic value of NT-proBNP at rest and peak exercise in patients with impaired left ventricular function. Angiology. 2012;63(7):516-21. DOI: 10.1177/000331971142932810.1177/000331971142932822156406]Search in Google Scholar
[13. Cipriano G Jr, Cipriano VT, da Silva VZ, Cipriano GF, Chiappa GR, de Lima AC, et al. Aerobic exercise effect on prognostic markers for systolic heart failure patients: a systematic review and meta-analysis. Heart Fail Rev. 2013 Oct 16 [Epub ahead of print]. DOI: 10.1007/s10741-013-9407-610.1007/s10741-013-9407-624129770]Search in Google Scholar
[14. Ingle L, Rigby AS, Carroll S, Butterly R, King RF, Cooke CB, et al. Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure. Eur Heart J 2007;28(5):560-8. DOI: 10.1093/eurheartj/ehl52710.1093/eurheartj/ehl52717314108]Search in Google Scholar
[15. Hogenius J, Voors AA, Jaarsma T, Hillege HL, Boomsma F, van Veldhuisen DJ. Influence of age on natriuretic peptide in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur J Heart Fail. 2005;7(1):81-6. DOI: 10.1016/j.ejheart. 2004.03.014]Search in Google Scholar
[16. Magne J, Mahjoub H, Pibarot P, Pirlet C, Pierard LA, Lancellotti P. Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation. Eur J Heart Fail. 2012;14(11):1293-302. DOI: 10.1093/eurjhf/hfs11410.1093/eurjhf/hfs11422782970]Search in Google Scholar
[17. Huang WS, Lee MS, Perng HW, Yang SP, Kuo SW, Chang HD. Circulating brain natriuretic peptide values in healthy men before and after exercise. Metabolism. 2002;51(11):1423-6. DOI: 10.1053/meta.2002.3519410.1053/meta.2002.3519412404192]Search in Google Scholar
[18. Krupicka J, Janota T, Kasalová Z, Hradec J. Effect of short-term maximal exercise on BNP plasma levels in healthy individuals. Physiol Res. 2010;59(4):625-8.10.33549/physiolres.93177319929142]Search in Google Scholar
[19. Foote RS, Pearlman JD, Siegel AH, Yeo KT. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol. 2004 ;44(10):1980-7. DOI: 10.1016/j.jacc.2004.08.04510.1016/j.jacc.2004.08.04515542280]Search in Google Scholar
[20. Staub D, Jonas N, Zellweger MJ, Nusbaumer C, Wild D, Pfisterer ME, et al. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. Am J Med. 2005;118(11):1287. DOI: 10.1016/j.amjmed. 2005.05.020]Search in Google Scholar
[21. Mak GS, DeMaria A, Clopton P, Maisel AS. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J. 2004;148(5):895-902. DOI: 10.1016/j.ahj.2004.02.01610.1016/j.ahj.2004.02.01615523324]Search in Google Scholar
[22. Chinnaiyan KM, Alexander D, Maddens M, Mc- Cullough PA. Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure. Am Heart J. 2007;153 (2):189-200. DOI: 10.1016/j. ahj.2006.10.022]Search in Google Scholar
[23. Zdrenghea D, Pop D, Ilea M. Cardiac Peptides During Isometric Exercise in Patients With Diastolic Dysfunction. Current Advances in Heart Disease. 2008;265-8.]Search in Google Scholar
[24. Danzig V, Míková B, Kuchynka P, Benáková H, Zima T, Kittnar O, et al . Levels of circulating biomarkers at rest and after exercise in coronary artery disease patients. Physiol Res. 2010;59(3):385-92.10.33549/physiolres.93176419681661]Search in Google Scholar
[25. Guazzi M, Vitelli A, Arena R. The effect of exercise training on plasma NT-pro-BNP levels and its correlation with improved exercise ventilatory efficiency in patients with heart failure. Int J Cardiol. 2012;158(2):290-1. DOI: 10.1016/j.ijcard.2012.04.09110.1016/j.ijcard.2012.04.09122608896]Search in Google Scholar
[26. Madaric J, Watripont P, Bartunek J, Casselman F, Vanderheyden M, Van Praet F, et al. Effect of mitral valve repair on exercise tolerance in asymptomatic patients with organic mitral regurgitation. Am Heart J. 2007;154(1):180-5. DOI: 10.1016/j.ahj.2007.03.05110.1016/j.ahj.2007.03.05117584574]Search in Google Scholar
[27. Mak GS, DeMaria A, Clopton P, Maisel AS. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J. 2004;148(5):895-902. DOI: 10.1016/j.ahj.2004.02.01610.1016/j.ahj.2004.02.016]Search in Google Scholar
[28. Suntharalingam J, Goldsmith K, Toshner M, Doughty N, Sheares KK, Hughes R, et al. Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension. Respir Med. 2007;101(11):2254-62. DOI: 10.1016/j.rmed.2007.06.02710.1016/j.rmed.2007.06.02717706409]Search in Google Scholar
[29. Frantz RP, McDevitt S, Walker S. Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1. J Heart Lung Transplant. 2012;31(8):811-6. DOI: 10.1016/j. healun.2012.04.005 ]Search in Google Scholar